[HTML][HTML] Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other …
SR Mullins, JP Vasilakos, K Deschler, I Grigsby… - … for immunotherapy of …, 2019 - Springer
Background Immune checkpoint blockade (ICB) promotes adaptive immunity and tumor
regression in some cancer patients. However, in patients with immunologically “cold” …
regression in some cancer patients. However, in patients with immunologically “cold” …
Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 …
EC Swanson, P Gillis, N Hernandez-Alvarado… - Vaccine, 2015 - Elsevier
Cytomegalovirus (CMV) subunit vaccine candidates include glycoprotein B (gB), and
phosphoprotein ppUL83 (pp65). Using a guinea pig cytomegalovirus (GPCMV) model, this …
phosphoprotein ppUL83 (pp65). Using a guinea pig cytomegalovirus (GPCMV) model, this …